Search

Zimmer Biomet Holdings Inc

Chiusa

SettoreSettore sanitario

95 0.81

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

95

Massimo

95.82

Metriche Chiave

By Trading Economics

Entrata

-39M

200M

Vendite

90M

2.2B

P/E

Media del settore

23.432

56.432

EPS

2.07

Rendimento da dividendi

1.03

Margine di Profitto

9.169

Dipendenti

17,000

EBITDA

-210M

328M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+11.23% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

1.03%

2.27%

Utili prossimi

4 nov 2026

Prossima data del Dividendo

30 ott 2026

Prossima data del' Ex Dividendo

29 set 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-348M

18B

Apertura precedente

94.19

Chiusura precedente

95

Notizie sul Sentiment di mercato

By Acuity

25%

75%

28 / 339 Classifica in Healthcare

Zimmer Biomet Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 set 2026, 21:51 UTC

Zimmer Biomet Holdings, Inc. is advancing in after-market trading, moving higher alongside the broader market despite concerns over U.S. economic momentum.

16 set 2026, 20:07 UTC

Zimmer Biomet Holdings, Inc. shares fell sharply, retracing from earlier gains and remaining below the 20-day moving average amid a decline since Tuesday's close.

15 set 2026, 20:03 UTC

Zimmer Biomet shares are higher today, continuing positive momentum from Monday. This follows an early dip amid broader market concerns over New York's manufacturing sector.

14 set 2026, 22:01 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, continuing a trend of gains since Monday's close. No specific news was identified.

11 set 2026, 23:46 UTC

Zimmer Biomet Holdings shares advanced in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

10 set 2026, 20:03 UTC

Zimmer Biomet Holdings is declining during Thursday's session, continuing a downward trend since Wednesday's close with no specific news identified for the movement.

9 set 2026, 22:51 UTC

Zimmer Biomet Holdings is trading lower in after-market hours amid a broader decline in U.S. stocks linked to rising crude oil prices above $100.

8 set 2026, 21:02 UTC

News

Zimmer Biomet announced leadership promotions to enhance its strategy and reaffirmed its 2026 financial outlook. Shares are higher in after-market trading.

4 set 2026, 20:07 UTC

Shares of Zimmer Biomet Holdings are lower today, amid increased selling pressure following a strong jobs report. The stock remains below its 20-day moving average.

2 set 2026, 20:08 UTC

Zimmer Biomet shares are higher today, benefiting from significant advances in Health Care Equipment stocks. No specific news was identified to explain the movement.

1 set 2026, 21:51 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, nearing the top of their one-month range, amid broader market volatility and rising crude oil prices.

31 ago 2026, 20:07 UTC

Shares of Zimmer Biomet Holdings are trading lower amid market pressure from heightened interest rate hike expectations following the Jackson Hole Economic Symposium.

28 ago 2026, 19:16 UTC

Zimmer Biomet Holdings is trading higher during Friday's session, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

27 ago 2026, 20:02 UTC

Zimmer Biomet Holdings, Inc. shares are lower as Health Care Equipment stocks face pressure, marking a shift from recent upward trends. No specific news was identified.

26 ago 2026, 19:26 UTC

Zimmer Biomet Holdings is trading higher, supported by strength above its 20-day moving average amid broader market dynamics and rising U.S. consumer prices.

25 ago 2026, 23:31 UTC

Zimmer Biomet Holdings is trading lower in after-market hours. This decline comes amid broader market sentiment impacted by a significant drop in crude oil prices.

24 ago 2026, 19:46 UTC

Zimmer Biomet Holdings is trading higher today, with shares near the upper end of their one-month range amid rising oil prices and geopolitical tensions.

22 ago 2026, 00:01 UTC

Zimmer Biomet Holdings Inc. shares are lower in after-market hours, reflecting broader weakness despite remaining above the 20-day moving average.

21 ago 2026, 23:01 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours, with no specific news identified. Recent bond market volatility may be influencing trader sentiment.

19 ago 2026, 20:06 UTC

Zimmer Biomet Holdings Inc is trading higher today, marking a shift from its recent trend of higher daily closes since Tuesday. No specific news was identified.

18 ago 2026, 19:16 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. reported first-quarter revenue of $2.05 billion, exceeding estimates. Shares are advancing amid raised full-year guidance and positive sector sentiment.

17 ago 2026, 20:02 UTC

Zimmer Biomet Holdings Inc shares are lower today, continuing a decline since Friday amid broader market pressures and rising crude oil prices.

14 ago 2026, 19:26 UTC

News

Zimmer Biomet Holdings Inc. shares are higher following Q2 earnings that topped estimates, with revenue of $2.18 billion and adjusted EPS of $2.07.

13 ago 2026, 19:46 UTC

Shares of Zimmer Biomet Holdings are trading higher, remaining strong near the upper end of their one-month range amid positive broader market sentiment.

12 ago 2026, 23:21 UTC

Zimmer Biomet Holdings Inc. shares are roughly flat in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 ago 2026, 23:02 UTC

Zimmer Biomet Holdings Inc. shares are higher in after-market trading, moving within a range above its 20-day moving average and near a one-month high.

10 ago 2026, 19:56 UTC

Correlated Moves
News

Canaccord raised Zimmer Biomet's price target to $100 from $83, maintaining a Hold rating. Shares are higher since Friday's close amid market strength.

7 ago 2026, 19:46 UTC

News

Zimmer Biomet shares are lower today as Truist maintains a Hold rating but raises the price target to $106 amid cautious market conditions.

6 ago 2026, 19:52 UTC

News

Zimmer Biomet shares are lower today, despite price target increases from RBC, BMO, and Wells Fargo. This marks a shift from recent higher daily closes.

5 ago 2026, 23:02 UTC

News

Stifel raised the price target on Zimmer Biomet to $110 from $105, maintaining a Buy rating. Shares are higher in after-market trading.

Confronto tra pari

Modifica del prezzo

Zimmer Biomet Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

11.23% in crescita

Previsioni per 12 mesi

Media 106.067 USD  11.23%

Alto 120 USD

Basso 93 USD

Basato su 18 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zimmer Biomet Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

18 ratings

6

Acquista

12

Mantieni

0

Vendi

Sentiment

By Acuity

28 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.